A heart-shaped note was found in socks bound for Luigi Mangione, prosecutors say
NEW YORK (AP) — Someone tucked a heart-shaped note of encouragement into socks packed for Luigi Mangione to wear to court ...
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Successfully Completed Private Placements with Aggregate Gross Proceeds of Approximately $125 Million to Support Advancement of Two ...
News-Medical.Net1d
High-salt diet induces depression-like symptoms in mice
A new study published in The Journal of Immunology found that a high-salt diet (HSD) induces depression-like symptoms in mice by driving the production of a protein called IL-17A.
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...
manilatimes9d
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo
Cardiology Fellow, UMKC Healthcare Institute for Innovations in Quality, Saint Luke's Mid America Heart Institute ... any ...
Le Lézard14d
BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight
DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a ...
Le Lézard15d
Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention
FDA 510(k) clearance of Caristo's CaRi-Plaquetm technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...
Finanznachrichten22d
Windtree Therapeutics: Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure
March 04, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or ... is pleased to announce that the United States Patent and Trademark Office has issued a Notice of Allowance for ...
Benzinga.com22d
Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
On Tuesday, the FDA accepted for review Capricor Therapeutics Inc’s CAPR Biologics ... DMD cardiomyopathy is a heart condition characterized by cardiac fibrosis, arrhythmias, and heart failure.
Yahoo Finance22d
Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
and heart failure. Additionally, the FDA granted the BLA Priority Review with a Prescription Drug User Fee Act (PDUFA) target action date of August 31, 2025. The FDA has not identified any potential ...
Business Wire22d
Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD
--(BUSINESS WIRE)--Cadrenal Therapeutics ... heart pumps have set the standard in LVAD therapy. The HeartMate 3™ LVAD is the most advanced LVAD yet and the only one currently available in the ...
Morningstar22d
Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD
Abbott’s heart pumps have set the standard in LVAD therapy. The HeartMate 3™ LVAD is the most advanced LVAD yet and the only one currently available in the United States. According to Business ...